. 2022 Jun 28;7(27):23736–23743. doi: 10.1021/acsomega.2c02380

Table 2. Anti-H. pylori Activity of Compounds 1–9 against H. pylori Strain 51 Treated with 100 μM of Each Compound.

compound	inhibition (%)	MIC₅₀ (μM)	MIC₉₀ (μM)
1	8.1
2	0.0
3	94.4	22	50
4	14.8
5	58.6	99	>100
6	15.7
7	20.0
8	7.1
9	16.1
quercetin^a	34.4
metronidazole^a	97.0	17	46

Positive controls.